During his Rose Garden address last month, Biden reaffirmed his support for repealing the
“This is the only outfit that is exempt from being sued. If I get one thing on my list (if) the Lord came down and said, ‘Joe, you get one of these’ give me that one,” Biden said. “Most people don’t realize, the only industry in America, billion-dollar industry, that can’t be sued, exempt from being sued, are gun manufacturers.”
Biden’s hostility to this industry, however, isn’t new.
As a U.S. Senator, he voted against the PLCCA. Biden’s campaign listed repeal of the law as a top priority, stating, “This law protects these manufacturers from being held civilly liable for their products – a protection granted to no other industry. Biden will prioritize repealing this protection.”
President Joe Biden has the firearms industry in his crosshairs.
“This is the only outfit that is exempt from being sued. If I get one thing on my list (if) the Lord came down and said, Joe, you get one of these give me that one, Biden said. Most people don’t realize, the only industry in America, billion-dollar industry, that can’t be sued, exempt from being sued, are gun manufacturers.”
Biden’s hostility to this industry, however, isn’t new.
As a U.S. Senator, he voted against the PLCAA. Biden’s campaign listed repeal of the law as a top priority, stating, “This law protects these manufacturers from being held civilly liable for their products – a protection granted to no other industry. Biden will prioritize repealing this protection.”
Synopsis
Pfizer has signed an indemnity clause with many countries that are using its vaccine, absolving the company from paying any legal cost in case of an adverse event. Unlike many other countries, India does not offer any protection against adverse effects such as serious illness or death caused by the vaccine.
Reuters
Pfizer’s insistence that the government should indemnify it against lawsuits in case of adverse affects linked to its jab has become a major hurdle for its Covid-19 vaccine obtaining approval in India. The discussions are essentially stalled over the indemnity issue, people in the know told ET.
As COVID-19 vaccination roll-outs become more widespread in the United States and the European Union, employers should proactively consider the impact of vaccinations on return to work.